Redcare Pharmacy NV Share Price

Equities

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra 09:05:20 26/04/2024 pm IST 5-day change 1st Jan Change
130 EUR 0.00% Intraday chart for Redcare Pharmacy NV +0.78% -1.22%

Financials

Sales 2024 * 2.38B 2.54B 212B Sales 2025 * 2.91B 3.11B 259B Capitalization 2.63B 2.81B 234B
Net income 2024 * -8M -8.55M -713M Net income 2025 * 45M 48.11M 4.01B EV / Sales 2024 * 1.17 x
Net Debt 2024 * 154M 164M 13.69B Net Debt 2025 * 135M 144M 12.04B EV / Sales 2025 * 0.95 x
P/E ratio 2024 *
-261 x
P/E ratio 2025 *
67.8 x
Employees 1,900
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.87%
More Fundamentals * Assessed data
Dynamic Chart
1 week+0.78%
Current month-14.28%
1 month-7.83%
3 months-1.81%
6 months+16.96%
Current year-1.22%
More quotes
1 week
125.50
Extreme 125.5
142.30
1 month
125.50
Extreme 125.5
153.00
Current year
118.05
Extreme 118.05
153.00
1 year
81.64
Extreme 81.64
153.00
3 years
36.51
Extreme 36.51
189.00
5 years
28.30
Extreme 28.3
249.00
10 years
24.00
Extreme 24
249.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01/23/01
Director of Finance/CFO 51 01/20/01
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 52 01/16/01
Founder 60 01/01/01
Director/Board Member 53 14/22/14
More insiders
Date Price Change Volume
26/24/26 130 0.00% 115,616
25/24/25 130 -3.92% 170,092
24/24/24 135.3 +0.22% 108,909
23/24/23 135 +3.05% 98,781
22/24/22 131 +1.55% 47,526

Delayed Quote Xetra, April 26, 2024 at 09:05 pm IST

More quotes
Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
130 EUR
Average target price
155.2 EUR
Spread / Average Target
+19.37%
Consensus

Quarterly revenue - Rate of surprise